Related Experiment Video
Updated: Oct 14, 2025

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Routine laboratory parameters predict serious outcome as well as length of hospital stay in COVID-19
Mohammed A Jeraiby1, Majed I Hakamy1, Mohammed B Albarqi1
1From the Department of Medical Biochemistry (Jeraiby, Iqbal), Faculty of Medicine, Jazan University, from the Department of Pulmonology (Hakamy, Albarqi, Areda); and from the Department of Laboratory Medicine (Haddad), King Fahad Central Hospital, Jazan, Kingdom of Saudi Arabia.
Insights
C-reactive protein (CRP) is a better predictor of serious outcomes in COVID-19 patients than red cell distribution width (RDW) and neutrophil lymphocyte ratio (NLR). CRP also positively correlates with length of hospital stay (LOS), while mean corpuscular hemoglobin concentration (MCHC) shows a negative association.
Area of Science:
- Clinical Medicine
- Infectious Diseases
- Laboratory Hematology
Background:
- Hospitalized coronavirus disease-19 (COVID-19) patients face risks of serious outcomes and prolonged hospital stays.
- Biomarkers such as C-reactive protein (CRP), red cell distribution width (RDW), and neutrophil lymphocyte ratio (NLR) are routinely measured and may indicate disease severity.
Purpose of the Study:
- To validate the predictive capabilities of CRP, RDW, and NLR for serious outcomes in COVID-19 patients.
- To assess the association of these laboratory markers with the length of hospital stay (LOS) in hospitalized COVID-19 patients.
Main Methods:
- Retrospective cohort study involving 74 adult COVID-19 patients.
- Logistic regression and receiver operating curve analysis were used to evaluate risk factors for serious outcomes.
- Multiple regression analysis determined the association between routine laboratory analytes and LOS.
Main Results:
- Higher levels of CRP, white blood cells, and neutrophils were observed in patients with serious outcomes.
- CRP and RDW demonstrated significant predictive value for serious outcomes in both unadjusted and adjusted models.
- CRP showed a positive association with LOS, while mean corpuscular hemoglobin concentration (MCHC) exhibited a negative association.
Conclusions:
- C-reactive protein (CRP) is a more effective predictor of serious outcomes in COVID-19 patients compared to RDW and NLR.
- CRP levels are positively correlated with the length of hospital stay, indicating a potential link to disease duration.
- Mean corpuscular hemoglobin concentration (MCHC) is negatively associated with LOS, suggesting a possible protective role or different disease trajectory.
Objectives:
To validate C-reactive protein (CRP), red cell distribution width (RDW), and neutrophil lymphocyte ratio (NLR) for both serious outcomes and length of hospital stay (LOS) among hospitalized coronavirus disease-19 (COVID-19) patients.
Methods:
Laboratory data of adult COVID-19 patients (n=74) was collected in this retrospective cohort. Logistic regression was employed for risk factor evaluation and receiver operating curve was used for comparison of these risk factors for the prediction of serious outcome. Multiple regression was applied to determine the association between routine analytes and LOS.
Results:
Higher levels of CRP (3 times), white blood cells (20%), and neutrophil counts (40%) were seen in the serious category. Odds ratio for CRP for the serious outcome was 1.052 (p=0.007) and RDW for the serious outcome was 1.218 (p=0.040) in unadjusted model and odds ratio for CRP for the serious outcome was 1.048 (p=0.024) and for RDW 1.286 (p=0.023) in adjusted model. In a multivariate regression analysis for the LOS of the unadjusted models consisting of NLR, monocyte lymphocyte ratio (MLR) and platelet lymphocyte ratio (PLR), the beta coefficients (BC) for the CRP were 0.006 (NLR), 0.005 (MLR) and 0.006 (PLR), whereas -0.029 (NLR), -0.034 (MLR) and -0.027 (PLR) were BCs for mean corpuscular hemoglobin concentration (MCHC). Additionally, in adjusted models, the BCs for MCHC were -0.044 (NLR), -0.047 (MLR) and -0.043 (PLR). However, the CRP was consistent with 0.004 (BC) in all models.
Conclusion:
We observed that CRP is a better predictor than RDW and NLR for serious outcome among COVID-19 patients. Besides, CRP was positively, whereas MCHC was negatively associated with LOS.
Related Concept Videos
Pneumonia III: Complications and Assessment
Acute Coronary Syndrome III: Diagnostic Studies
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

